Correa et al.
7.43 (d, J ) 9.1, 2H), 7.53-7.59 (m, 1H), 7.88-7.91 (m, 1H); 13
NMR (CDCl3) δ 52.9, 55.4, 112.5, 114.4, 119.6, 120.6, 122.7,
124.3, 126.1, 127.7, 129.5, 132.3, 149.5, 158.3, 162.3; IR (KBr)
1679 cm-1; MS (EI) m/z (%) 280 (M+, 24), 240 (18), 239 (100),
196 (17), 168 (50), 140 (12), 135 (34), 107 (15), 92 (16), 77 (34);
HRMS calcd for C17H16N2O2 280.1212, found 280.1221.
C
alkyl (entries 7 and 8) or alkoxyamides (entry 9), they all failed
to afford the desired indazolone, and a complex mixture of
products was obtained in all cases. Similar results were observed
with amide 2l.22,23 Consequently, it must be pointed out that an
aromatic ring seems to be necessary to stabilize the correspond-
ing N-acylnitrenium intermediate.
Because of the obtained results and taking into account that
a radical mechanism can be discarded, supported by the fact
that either an oxygen atmosphere or an addition of a radical
trap such as TEMPO or DPPH24 did not affect the projected
reaction at all, it can be proposed that this novel N-N bond
formation takes place through an N-acylnitrenium ion generated
by the action of the mild oxidant PIFA on aromatic amides.
These intermediates react intramolecularly with the amine
moiety, as the nucleophilic partner of the reaction, giving rise
to the highly valued heterocyclic systems 3.
1-Benzyl-2-(4-methoxyphenyl)-1,2-dihydro-3H-indazol-3-
one (3c). According to the general procedure, indazolone 3c was
obtained from benzamide 2c in 67% yield as a yellowish solid after
purification by column chromatography (hexanes/EtOAc, 1:1)
followed by crystallization from hexanes: mp 148-149 °C
1
(hexanes); H NMR (CDCl3) δ 3.86 (s, 3H), 4.72 (s, 2H), 6.89-
7.28 (m, 9H), 7.45-7.57 (m, 3H), 7.82-7.85 (m, 1H); 13C NMR
(CDCl3) δ 54.2, 55.4, 112.9, 114.4, 119.5, 122.6, 124.3, 125.9,
127.8, 128.2, 128.4, 132.1, 133.5, 149.5, 158.2, 162.3; IR (KBr)
1678 cm-1; MS (EI) m/z (%) 330 (M+, 20), 239 (100), 196 (15),
168 (35), 135 (27), 107 (12), 91 (35), 77 (38); HRMS calcd for
C21H18N2O2 330.1368, found 330.1368.
2-(4-Methoxyphenyl)-1-phenyl-1,2-dihydro-3H-indazol-3-
one (3d). According to the general procedure, indazolone 3d was
obtained from benzamide 2d in 61% yield as a white solid after
purification by column chromatography (hexanes/EtOAc, 1:1)
followed by crystallization from hexanes: mp 146-147 °C
(hexanes); 1H NMR (CDCl3) δ 3.74 (s, 3H), 6.86 (d, J ) 8.7, 2H),
7.15-7.53 (m, 10H), 7.95-7.98 (m, 1H); 13C NMR (CDCl3) δ 55.3,
112.2, 114.1, 118.0, 123.1, 124.2, 124.4, 125.2, 127.5, 128.5, 129.5,
132.7, 141.9, 149.7, 157.6, 162.5; IR (KBr) 1678 cm-1; MS (EI)
m/z (%) 316 (M+, 100), 301 (29), 273 (13), 193 (18), 167 (52), 77
(90), 51 (45); HRMS calcd for C20H16N2O2 316.1212, found
316.1213.
1-Methyl-2-phenyl-1,2-dihydro-3H-indazol-3-one (3h). Ac-
cording to the general procedure, indazolone 3h was obtained from
benzanilide 2h in 60% yield as a colorless oil after purification by
column chromatography (hexanes/EtOAc, 1:1). 1H NMR (CDCl3)
δ 3.13 (s, 3H), 7.20-7.29 (m, 3H), 7.44-7.62 (m, 5H), 7.88-
7.91 (m, 1H); 13C NMR (CDCl3) δ 39.5, 112.4, 118.9, 122.9, 123.5,
124.4, 126.2, 129.0, 132.7, 134.9, 151.6, 162.1; IR (KBr) 1684
cm-1; MS (EI) m/z (%) 224 (M+, 100), 209 (59), 153 (26), 152
(46), 132 (21), 105 (18), 77 (47); HRMS calcd for C21H18N2O
224.0950, found 224.0950.
1-Methyl-2-(1-naphthyl)-1,2-dihydro-3H-indazol-3-one (3i).
According to the general procedure, indazolone 3i was obtained
from benzamide 2i in 61% yield as a brown solid after purification
by column chromatography (hexanes/EtOAc, 1:1) followed by
crystallization from hexanes: mp 160-161 °C (hexanes); 1H NMR
(CDCl3) δ 3.06 (s, 3H), 7.25-7.31 (m, 2H), 7.50-7.67 (m, 5H),
7.78-8.02 (m, 4H); 13C NMR (CDCl3) δ 37.9, 111.8, 118.1, 122.4,
123.4, 124.4, 125.2, 126.4, 126.5, 127.0, 128.1, 129.4, 130.4, 130.9,
132.5, 134.3, 150.9, 162.7; IR (KBr) 1678 cm-1; MS (EI) m/z (%)
274 (M+, 100), 257 (14), 245 (22), 202 (21), 144 (27), 132 (28),
127 (28), 104 (19); HRMS calcd for C18H14N2O 274.1106, found
274.1106.
2-(4-Ethylphenyl)-1-methyl-1,2-dihydro-3H-indazol-3-one (3j).
According to the general procedure, indazolone 3j was obtained
from benzamide 2j in 60% yield as a brown solid after purification
by column chromatography (hexanes/EtOAc, 1:1) followed by
crystallization from hexanes: mp 101-103 °C (hexanes); 1H NMR
(CDCl3) δ 1.25 (t, J ) 7.1, 3H), 2.67 (q, J ) 7.1, 2H), 3.12 (s,
3H), 7.19-7.31 (m, 4H), 7.45-7.58 (m, 3H), 7.88-7.91 (m, 1H);
13C NMR (CDCl3) δ 15.5, 28.4, 39.3, 112.3, 112.8, 118.9, 123.8,
124.3, 128.5, 132.5, 142.6, 151.4, 161.9; IR (KBr) 1684 cm-1; MS
(EI) m/z (%) 252 (M+, 100), 237 (49), 165 (17), 132 (22), 105
(14), 77 (30); HRMS calcd for C16H16N2O 252.1263, found
252.1262.
Conclusions
In conclusion, the powerful potential of the inexpensive and
easy-to-handle hypervalent iodine reagent PIFA in organic
synthesis, which includes its ability to generate N-acylnitrenium
ions from adequately substituted amides under rather mild
conditions, has been employed satisfactorily in the preparation
of a series of N,N′-disubstituted indazolones. Our approach
features the first successful intramolecular trapping of N-
acylnitrenium ions by amine functionalities, developing a novel
versatile method for the construction of new N-N linkages and
hence offering easy access to a diverse array of N-heterocyclic
compounds.
Experimental Section
Typical Procedure for the Synthesis of Indazolones 3a-d,h-
k. Synthesis of 2-(4-Methoxyphenyl)-1-methyl-1,2-dihydro-3H-
indazol-3-one (3a). A solution of PIFA (252 mg, 0.78 mmol) in
78 mL of CH2Cl2 was added at 0 °C to a solution of benzamide 2a
(100 mg, 0.39 mmol) and TFA (0.09 mL, 1.91 mmol) in 39 mL of
the same solvent, and the new solution was stirred for 1 h. Then,
the solvent was evaporated at reduced pressure, and the resulting
residue was purified by column chromatography (hexanes/EtOAc,
1:1) followed by crystallization from hexanes to afford indazolone
1
3a as a white solid (68% yield): mp 117-118 °C (hexanes); H
NMR (CDCl3) δ 3.17 (s, 3H), 3.89 (s, 3H), 7.07 (d, J ) 9.1, 2H),
7.29-7.35 (m, 2H), 7.52 (d, J ) 9.1, 2H), 7.62-7.68 (m, 1H),
7.95-5.98 (s, 1H); 13C NMR (CDCl3) δ 38.9, 55.3, 112.1, 114.2,
118.7, 122.6, 124.1, 125.6, 127.6, 132.3, 151.1, 158.1, 161.9; IR
(KBr) 1678 cm-1; MS (EI) m/z (%) 254 (M+, 100), 239 (44), 168
(30), 135 (16), 132 (18), 77 (24); HRMS calcd for C15H14N2O2
254.1055, found 254.1057.
1-Allyl-2-(4-methoxyphenyl)-1,2-dihydro-3H-indazol-3-one (3b).
According to the general procedure, indazolone 3b was obtained
from benzamide 2b in 62% yield as a yellowish oil after purification
by column chromatography (hexanes/EtOAc, 1:1): 1H NMR
(CDCl3) δ 3.83 (s, 3H), 4.15-4.17 (m, 2H), 4.97-5.07 (m, 2H),
5.35-5.51 (m, 1H), 7.00 (d, J ) 9.1, 2H), 7.18-7.30 (m, 2H),
(22) Because the AlMe3-mediated aminolysis of methylanthranilate 1a
in the presence of NH3 failed to afford the desired primary amide, it was
prepared by treating the commercially available N-methylanthranilamide
with methyl iodide at 100 °C following a described protocol in: Chatterjee,
A.; Majudmar, S. G. J. Am. Chem. Soc. 1953, 75, 4365-4366.
(23) Primary amides have been reported to suffer Hofmann-type rear-
rangements using various iodine(III) reagents. However, in our case, such
types of products were not detected. See: Prakash, O.; Batra, H.; Kaur, H.;
Sharma, P. K.; Sharma, V.; Singh, S. P.; Moriarty, R. M. Synthesis 2001,
541-543.
2-(4-Bromophenyl)-1-methyl-1,2-dihydro-3H-indazol-3-one (3k).
According to the general procedure, indazolone 3k was obtained
from benzamide 2k in 45% yield as a brown solid after purification
by column chromatography (hexanes/EtOAc, 1:1) followed by
crystallization from hexanes: mp 112-114 °C (hexanes); 1H NMR
(24) Kawase, M.; Kitamura, T.; Kikugawa, Y. J. Org. Chem. 1989, 54,
3394-3403.
3504 J. Org. Chem., Vol. 71, No. 9, 2006